Senti Biosciences Holdings, Inc. (SNTI)
0.3868
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
0.3868
0.00 (0.00%)
After-Hours: 16:32
Senti Biosciences Holdings Total Liabilities (Quarterly) : 36.51M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.51M |
| March 31, 2026 | 35.68M |
| December 31, 2025 | 45.63M |
| September 30, 2025 | 37.14M |
| June 30, 2025 | 36.47M |
| March 31, 2025 | 44.92M |
| December 31, 2024 | 47.09M |
| September 30, 2024 | 41.73M |
| June 30, 2024 | 42.76M |
| March 31, 2024 | 46.09M |
| December 31, 2023 | 52.57M |
| Date | Value |
|---|---|
| September 30, 2023 | 48.83M |
| June 30, 2023 | 46.21M |
| March 31, 2023 | 49.08M |
| December 31, 2022 | 53.53M |
| September 30, 2022 | 49.10M |
| June 30, 2022 | 48.10M |
| March 31, 2022 | 11.10M |
| December 31, 2021 | 36.33M |
| September 30, 2021 | 8.179M |
| June 30, 2021 | 8.111M |
| March 31, 2021 | 0.3498M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovelStem International Corp. | 2.097M |
| Brainstorm Cell Therapeutics, Inc. | 12.38M |
| Summit Therapeutics, Inc. | 122.20M |
| Kezar Life Sciences, Inc. | 2.762M |
| Protara Therapeutics, Inc. | 14.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.10M |
| Shareholders Equity (Quarterly) | -3.401M |
| Debt to Equity Ratio | -5.947 |
| Current Ratio | 0.8251 |
| Net Debt Paydown Yield | 7.13% |